UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 5, 2023 5:30 P.M.

Form:	S-4
CIK: 0001603207 Company Name: Vascular Biogenics Ltd. File Number: 333-271826